Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary P Coffey

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
International Immunopharmacology|May 27, 2014
Specific binding of intravenous immunoglobulin products to tau peptide fragmentsLynnae M Smith, Mary P Coffey, David A Loeffler
The Journal of Pediatrics|June 12, 2020
Heme Catabolism and Bilirubin Production in Readmitted Jaundiced NewbornsM Jeffrey Maisels, Elizabeth A Kring, Mary P Coffey
International Immunopharmacology|September 3, 2015
ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin productsDavid A Loeffler, Andrea C Klaver, Mary P Coffey
OTO Open|November 28, 2018
Middle Eastern Rhinoplasty: Relationship of the Nasal Spine and Caudal Septum to Tip Projection and Columellar-Labial AngleRichard L Arden, Brett J Baldwin, Mary P Coffey
Autoimmunity|November 14, 2014
Aβ anti-idiotypic antibodies are present in intravenous immunoglobulin and are produced in mice following its administrationDavid A Loeffler, Andrea C Klaver, Mary P Coffey
Brain Research|February 20, 2018
CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutationsAndrea C Klaver, Mary P Coffey, Jan O Aasly, et al.
International Immunopharmacology|May 15, 2013
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau proteinLynnae M Smith, Mary P Coffey, Andrea C Klaver, et al.
Journal of Parkinson'S Disease|July 20, 2019
What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?David A Loeffler, Jan O Aasly, Peter A LeWitt, et al.
Immunology Letters|August 10, 2013
Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodiesAndrea C Klaver, Mary P Coffey, Lynnae M Smith, et al.
Frontiers in Aging Neuroscience|June 6, 2018
Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal AgingDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
International Immunopharmacology|May 27, 2014
Specific binding of intravenous immunoglobulin products to tau peptide fragmentsLynnae M Smith, Mary P Coffey, David A Loeffler
The Journal of Pediatrics|June 12, 2020
Heme Catabolism and Bilirubin Production in Readmitted Jaundiced NewbornsM Jeffrey Maisels, Elizabeth A Kring, Mary P Coffey
International Immunopharmacology|September 3, 2015
ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin productsDavid A Loeffler, Andrea C Klaver, Mary P Coffey
OTO Open|November 28, 2018
Middle Eastern Rhinoplasty: Relationship of the Nasal Spine and Caudal Septum to Tip Projection and Columellar-Labial AngleRichard L Arden, Brett J Baldwin, Mary P Coffey
Autoimmunity|November 14, 2014
Aβ anti-idiotypic antibodies are present in intravenous immunoglobulin and are produced in mice following its administrationDavid A Loeffler, Andrea C Klaver, Mary P Coffey
Brain Research|February 20, 2018
CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutationsAndrea C Klaver, Mary P Coffey, Jan O Aasly, et al.
International Immunopharmacology|May 15, 2013
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau proteinLynnae M Smith, Mary P Coffey, Andrea C Klaver, et al.
Journal of Parkinson'S Disease|July 20, 2019
What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?David A Loeffler, Jan O Aasly, Peter A LeWitt, et al.
Immunology Letters|August 10, 2013
Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodiesAndrea C Klaver, Mary P Coffey, Lynnae M Smith, et al.
Frontiers in Aging Neuroscience|June 6, 2018
Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal AgingDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Pageof 3